TVGN
Tevogen Bio Holdings Inc.NASDAQHealthcare$4.46+11.55%ClosedMarket Cap: $18.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-2.01
P/S
0.00
EV/EBITDA
-0.89
DCF Value
$-1.68
FCF Yield
-61.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
316.0%
ROA
-599.5%
ROIC
3698.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-4.6M | $-4.7M | $-1.79 | — |
| FY 2025 | $0.00 | NaN% | $-26.1M | $-26.3M | $-8.08 | — |
| Q3 2025 | $0.00 | -Infinity% | $-5.7M | $-5.7M | $-1.50 | — |
| Q2 2025 | $0.00 | -Infinity% | $-5.4M | $-5.5M | $-1.53 | — |
| Q1 2025 | $0.00 | -Infinity% | $-10.4M | $-10.4M | $-3.26 | — |
| Q4 2024 | $0.00 | -Infinity% | $-9.4M | $-9.2M | $-2.60 | — |
| FY 2024 | $0.00 | -Infinity% | $-53.6M | $-10.1M | $-4.68 | — |
| Q3 2024 | $0.00 | -Infinity% | $-6.1M | $-5.9M | $-1.74 | — |
| Q2 2024 | $0.00 | -Infinity% | $-8.6M | $-6.1M | $-1.97 | — |
| Q1 2024 | $0.00 | -Infinity% | $-29.5M | $11.3M | $-13.00 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.0M | $-3.6M | $-0.26 | — |
| FY 2023 | $0.00 | -Infinity% | $-8.8M | $-60.5M | $-0.02 | — |